Evaluating The Role Of Montelukast In Management Of Acute Bronchiolitis | NCT07770464 | Trialant

RecruitingInterventionalPhase 2Updated Aug 18, 2026

Evaluating The Role Of Montelukast In Management Of Acute Bronchiolitis

Overview

Key facts that identify this study and show where it stands today.

What the study is about and why it is being run, in the researchers' own words.

Official Title: Evaluating The Role Of Montelukast In Management Of Acute Bronchiolitis
Brief Summary: This study aims to evaluate the role of Montelukast in management of acute Bronchiolitis in indoor patient and how this drug shortens the duration of admission and improves symptoms

The medical conditions and diseases this study investigates.

The treatments and procedures being evaluated in this study.

Who can join this study and the criteria used to decide.

Ages Eligible for Study: Child (0-17)
Sexes Eligible for Study: All
Accepts Healthy Volunteers: No
Eligibility Criteria: Inclusion Criteria

Age 4 weeks to 2 years

Both genders

Duration of respiratory symptoms less than 4 days

Clinical diagnosis of acute bronchiolitis according to the operational definition provided in the study protocol

Exclusion Criteria

History of asthma

Previous hospital admissions for respiratory illness

Use of asthma medications

Congenital heart disease

Bronchopulmonary dysplasia

Immunodeficiency

Immunosuppression

Radiological evidence of pneumonia, including infiltrates or patches on chest X-ray

How the study is designed and how its participant groups are organized.

The people to reach with questions about this study or how to join it.

Dr Haniyah Anwar, M.B.B.SContact

haniyahanwar@yahoo.com+92334-8359647

Where the study is run and whether each site is currently recruiting.

Pakistan Institute of Medical Sciences, IslamabadRecruiting

Islamabad, Federal 44000, Pakistan

The organizations and people involved in this study.

Other registered studies that closely resemble this one.